Anthropic has introduced Claude for Healthcare, a suite of artificial intelligence (AI)-based tools to assist healthcare providers, payers, and patients in conjunction with the kick-off of this year’s ...

With his pregnant wife undergoing life-altering surgery, Chris Carmack's character seeks a higher power in his time of need.

For individuals facing fear, uncertainty and repeated procedures associated with recurrent low-grade intermediate-risk bladder tumors, timely access to treatment can be critical. ZUSDURI, the first ...

What Is Driving the New Fair Value Estimate for Sight Sciences? Sight Sciences now carries a fair value estimate of US$9.35 ...

Anthropic is pushing into the healthcare market as it launches artificial intelligence tools and resources purpose-built for ...

The annual J.P. Morgan Healthcare Conference is officially underway, bringing the healthcare and biopharma industries' ...

Claude expands into healthcare and life sciences with HIPAA-ready tools, clinical trial support, and new connectors, ...

Interventional cardiologists say some cases that coders flag and submit to the NCDR aren’t in fact problematic.

Sight Sciences stock surged on Medicare coverage for TearCare—opening a big dry eye market. Learn more about the company.

Insurance verification expansion helps healthcare practices address eligibility challenges before patient visits.

ASC leaders have made significant advancements in technology, clinical efficiency and staffing in the last year and remain attentive to the constant stream of emerging tools to boost their practice’s ...